Zuffa and Dana White have issued statements regarding the news that Ali Bagautinov tested positive for EPO in the drug test he took before UFC 174.
“UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO). He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes. Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.”
In an interview with Yahoo! News, UFC President Dana White said he’s “beyond disappointed’ over Bagautinov’s drug use.
“We’re not paying lip service to this,” White said. “We’re trying to clean this up. It’s hurting everyone in the sport and we’re all over it.”